TuHURA

Beyond's analysis on TuHURA

• 2026-09-08 — TuHURA Biosciences to showcase immuno-oncology pipeline at H.C. Wainwright Investment Conference

Recent news mentioning TuHURA

• 2026-09-14 — TuHURA Biosciences Receives FDA "Study May Proceed" Notice and IND Clearance for the Evaluation of its TBS-2025 VISTA-Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood-Related Cancers
• 2026-09-08 — TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
• 2026-08-14 — TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Appears alongside

• FDA
• IND
• AML

Browse the full archive →